Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules

Summary

Decoy Therapeutics announced a warrant inducement transaction raising $3.85 million in gross proceeds at-the-market pricing under Nasdaq rules for its Designable Multi-Antivirals (D-MAVs) platform.